Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Autolus Therapeutics Plc ADR (NQ: AUTL )

2.620 -0.090 (-3.32%)
Streaming Delayed Price Updated: 3:10 PM EDT, May 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 63,934
Open 2.700
Bid (Size) 2.600 (7)
Ask (Size) 2.630 (2)
Prev. Close 2.710
Today's Range 2.590 - 2.700
52wk Range 2.200 - 8.230
Shares Outstanding 52,346,231
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Recap: Autolus Therapeutics Q4 Earnings
Autolus Therapeutics (NASDAQ:AUTL) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga

Performance

YTD
-52.01%
-52.01%
1 Month
-25.57%
-25.57%
3 Month
-34.66%
-34.66%
6 Month
-57.61%
-57.61%
1 Year
-58.81%
-58.81%

More News

Read More
Earnings Scheduled For March 10, 2022
Via Benzinga
40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
Why Autolus Therapeutics Stock Jumped 25% Today
Via The Motley Fool
Mid-Afternoon Market Update: eHealth Drops Following Q3 Results; Autolus Therapeutics Shares Gain
Via Benzinga
Topics Stocks
Exposures US Equities
58 Biggest Movers From Yesterday
Via Benzinga
Mid-Day Market Update: Trade Desk Jumps After Upbeat Results; GT Biopharma Shares Slide
Via Benzinga
Topics Stocks
Exposures US Equities
64 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
DSAC Stock Pops on FiscalNote SPAC Merger News. 14 Things to Know.
Via InvestorPlace
Chinese Stocks Alert: The Turnaround Story Driving TAL, EDU, METX, GOTU Stocks Higher
Via InvestorPlace
AUTL Stock: Why Little-Known Autolus Therapeutics Is Rocketing Higher Today
Via InvestorPlace
Mid-Morning Market Update: Markets Rise; Coty Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
26 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
Autolus Stock Rallies On $250M Investment From Blackstone
Via Benzinga
Allogene Craters To 52-Week Low On FDA Clinical Hold Of CAR-T Trials, Drags Peers As Well
Via Benzinga
Exposures Product Safety
Autolus' Blood Cancer CAR T-Cell Therapy Receives Promising Innovative Medicine In UK
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Here's Why Autolus Therapeutics Is Surging Today
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.